Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06381284 · ClinicalTrials.gov registry record
Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment
A clinical trial of Myasthenia Gravis and Neuromuscular Diseases, sponsored by ZS Associates.
- Completed
- Registry status
- 215
- Enrollment target
- 1
- Study location
NCT06381284 is a study of Myasthenia Gravis and Neuromuscular Diseases that has completed, run by ZS Associates. The registered enrollment target is 215 participants, above the 184-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (17% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06381284, a study of Myasthenia Gravis and Neuromuscular Diseases, has completed, sponsored by ZS Associates.
- COMPLETED
- Registry status
- 215 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The main study objective is to evaluate the feasibility of a social media recruitment campaign tied to a participant reported symptom survey and self-administered physical assessment tool to influence undiagnosed participants to seek care for suspected Myasthenia Gravis (MG).
Conditions Studied
Interventions
- BEHAVIORAL Social media recruitment
- BEHAVIORAL Self-Assessment
- BEHAVIORAL Follow-up
Study Locations (1)
Illinois
- ZS Associates - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2024-03-28 |
| Est. Completion | 2025-03-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06381284
The ClinicalTrials.gov registry entry for NCT06381284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 184-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (17% higher). The listed sponsor is ZS Associates, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Myasthenia Gravis appearing as the primary indexed condition, and to 3 interventions - of which Social media recruitment is the first listed.
NCT06381284 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06381284 about?
NCT06381284 is a clinical study titled "Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment". This is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The main study objective is to evaluate the feasibility of a social media recruitment campaign tied to a participant reporte...
What is the current status of trial NCT06381284?
This trial is currently completed. The enrollment target is 215 participants. The study started on 2024-03-28. Estimated completion is 2025-03-03.
What conditions does trial NCT06381284 study?
This clinical trial studies the following conditions: Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations.
What interventions are being tested in trial NCT06381284?
The interventions under investigation include: Social media recruitment (BEHAVIORAL), Self-Assessment (BEHAVIORAL), Follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT06381284?
This trial is sponsored by ZS Associates, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06381284 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.